Hikma Pharmaceuticals PLC
General ticker "HKMPF" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $5.7B (TTM average)
Hikma Pharmaceuticals PLC does not follow the US Stock Market performance with the rate: -35.9%.
Estimated limits based on current volatility of 1.0%: low 16.19$, high 16.52$
Factors to consider:
- Company pays dividends (semi-annually): last record date 2025-08-15, amount 0.36$ (Y4.39%)
Short-term HKMPF quotes
Long-term HKMPF plot
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $2,875.00MM | $3,127.00MM | $3,423.48MM |
| Operating Expenses | $2,508.00MM | $2,515.00MM | $2,785.60MM |
| Operating Income | $367.00MM | $612.00MM | $637.88MM |
| Non-Operating Income | $-86.00MM | $-157.00MM | $-107.34MM |
| Interest Expense | $89.10MM | $75.00MM | $108.36MM |
| R&D Expense | $149.00MM | $141.00MM | $154.36MM |
| Income(Loss) | $281.00MM | $455.00MM | $530.54MM |
| Taxes | $89.00MM | $93.00MM | $114.49MM |
| Profit(Loss)* | $190.00MM | $359.00MM | $410.94MM |
| Stockholders Equity | $2,198.00MM | $2,310.00MM | $2,597.14MM |
| Inventory | $891.00MM | $986.00MM | $1,107.77MM |
| Assets | $4,680.00MM | $5,133.00MM | $5,680.06MM |
| Operating Cash Flow | $608.00MM | $564.00MM | $366.98MM |
| Capital expenditure | $169.00MM | $165.00MM | $201.38MM |
| Investing Cash Flow | $-333.00MM | $-381.00MM | $-402.76MM |
| Financing Cash Flow | $-337.00MM | $-188.00MM | $59.29MM |
| Earnings Per Share** | $0.85 | $1.62 | $1.86 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.